ISSN 2410-7751 (Print)
ISSN 2410-776X (Online)
Biotechnologia Acta Т. 14, No. 6 , 2021
P. 61-69, Bibliography 22, Engl.
UDC: 57.088.3
https://doi.org/10.15407/biotech15.06.061
Full text: (PDF, in English)
STANDARDIZATION OF THE PROTEIN CALIBRATORS ISOLATION METHODOLOGY FOR THROMBOPHILIA MARKERS DETECTING IMMUNODIAGNOSTIC TEST SYSTEMS
Daria Korolova1, Myroslav Syrko1, 2, Yevhenii Stohnii1, Nadiia Druzhyna1, Tamara Chernyshenko1, Genrietta Gogolinska1
1 Palladin Institute of Biochemistry of the National Academy of Sciences, Kyiv, Ukraine
2 Taras Shevchenko National University of Kyiv, Ukraine
The most accurate laboratory methods for thrombophilia diagnostics are based on the quantitative determination of the blood plasma specific markers that appear as a result of the coagulation cascade activation. Soluble fibrin and D-dimer belong to the main of the last ones. An alteration in the concentration of such markers can indicate thrombin concentration growth and the formation of soluble oligomeric fibrin. It should be pointed out that simultaneous detection of these markers can establish the correlation between the accumulation of soluble fibrin and fibrinolysis and nowadays is provided only by enzyme-linked immunoassay. Thus, the usage of immunodiagnostic test systems for the detection of thrombophilia markers is highly relevant today. The important components of immunodiagnostic test system are protein calibrators, the isolation standardization of which plays a key role for accurate construction of a calibration curve and obtaining objective results as a consequence.
Aim. The objective of this study was to develop the soluble fibrin and D-dimer isolation methodology and its standardization for their further use as the protein calibrators for thrombophilia markers detecting immunodiagnostic test systems.
Materials and Methods. Soluble fibrin and D-dimer were isolated from collected human blood by fibrinogen salting out with further fibrin polymerization with thrombin and hydrolysis with plasmin. Quality control of the obtained proteins was carried out using SDS-PAGE and turbidimetric measurements with further checking of the proteins as calibrators for the thrombophilia markers detecting immunoassay.
Results. Obtained proteins meet the necessary specifications and can be used as calibrators for immunodiagnostic test systems. Soluble fibrin and D-dimer were checked by SDS-PAGE for the absence of impurities. Turbidimetric measurements showed the polymerization capability of the soluble fibrin and the inhibition of the polymerization by D-dimer.
Conclusion. The standardized isolation methodology of soluble fibrin and D-dimer can be used to obtain protein calibrators for appropriate immunodiagnostic test systems.
Key words: protein calibrators, thrombophilia, soluble fibrin, D-dimer, immunodiagnostic test systems
© Palladin Institute of Biochemistry of the National Academy of Sciences of Ukraine, 2022
Refrences
1. Heit J. Thrombophilia: common questions on laboratory assessment and management. Hematology Am. Soc. Hematol. Educ. Program. 2007, 1, 127—35. https://doi.org/10.1182/asheducation-2007.1.127
2. Kwaan H., Lindholm P. Fibrin and Fibrinolysis in Cancer. Semin Thromb Hemost. 2019, 45(4), 413-422. https://doi.org/10.1055/s-0039-1688495
3. Takahashi D., Takahashi Y., Matsui M., Araki S., Kubo K., Sato H., Shirahata A. Evaluation of hypercoagulability using soluble fibrin monomer complex in sick newborns. Pediatr. Int. 2013, 55(2), 151–6. https://doi.org/10.1111/ped.12050
4. Chernyshenko V., Snezhkova E., Mazur M., Chernyshenko T., Platonova T., Sydorenko O., Lugovskoy E., Nikolaev V. Blood coagulation parameters in rats with acute radiation syndrome receiving activated carbon as a preventive remedy. Ukr. Biochem. J. 2019, 91(2), 52-62. https://doi.org/10.15407/ubj91.02.052
5. Lugovskoy E., Kolesnikova I., Platonova T., Lugovskaya N., Litvinova L., Kostyuchenko E., Chernyshenko T., Ganova L., Komissarenko S. Simultaneous quantification of soluble fibrin and D-dimer in blood plasma for the assessment of the threat of thrombosis. Clinical Medicine. 2013, 11, 38-44.
6. Komisarenko S., Deev V., Luhovskyi E., Kolesnikova I., Platonova T., Luhovska N., Kostyuchenko O., Chernyshenko V., Koroleva D., Chernyshenko T., Liksunov O., Kashirova O., Romanova E. Application of immunoenzymatic methods for laboratory diagnosis of the threat of intravascular thrombus formation. Byhun V. Yu. 2019, 1-36.
7. Stang L., Mitchell L. Fibrinogen. Methods Mol. Biol. 2013, 992, 181-92. https://doi.org/10.1007/978-1-62703-339-8_14
8. Schafer K., Goldschmidt E., Oostra D., Fish J., Russell T., Lurie F. The clinical significance of ultra-high D-dimer levels. J. Vasc. Surg. Venous Lymphat. Disord. 2022, 10(1), 8–13. https://doi.org/10.1016/j.jvsv.2021.06.011
9. Refaai M., Riley P., Mardovina T., Bell P. The Clinical Significance of Fibrin Monomers. Thromb Haemost. 2018, 118(11), 1856-1866. https://doi.org/10.1055/s-0038-1673684
10. Hoshino K., Muranishi K., Kawano Y., Hatomoto H., Yamasaki S., Nakamura Y., Ishikura H. Soluble fibrin is a useful marker for predicting extracorporeal membrane oxygenation circuit exchange because of circuit clots. J Artif Organs. 2018, 21(2), 196-200. https://doi.org/10.1007/s10047-018-1021-x
11. Horan J., Francis C. Fibrin degradation products, fibrin monomer and soluble fibrin in disseminated intravascular coagulation. Semin Thromb Hemost. 2001, 27(6), 657-66. https://doi.org/10.1055/s-2001-18870
12. Lugovskoy E, Kolesnikova I., Komisarenko S. Usage of monoclonal antibodies for determination of localization of antigenic determinants and fibrin polymerization sites within fibrinogen and fibrin molecules and their application in test-systems for diagnostics and the threat of thrombus formation. Biotechnologia Acta. 2013, 6(4), 33-42. https://doi.org/10.15407/biotech6.04.033
13. Litvinov R., Pieters M., Lange-Loots Z., Weisel J. Fibrinogen and Fibrin. Subcell Biochem. 2021, 96, 471-501. https://doi.org/10.1007/978-3-030-58971-4_15
14. Yao Y., Cao J., Wang Q., Shi Q., Liu K., Luo Z., Chen X., Chen S., Yu K., Huang Z., Hu B. D-dimer as a biomarker for disease severity and mortality in COVID-19 patients: a case control study. Journal of intensive care 2020, 8, 49. https://doi.org/10.1186/s40560-020-00466-z
15. Poudel A., Poudel Y., Adhikari A., Aryal B., Dangol D., Bajracharya T., Maharjan A., Gautam R. D-dimer as a biomarker for assessment of COVID-19 prognosis: D-dimer levels on admission and its role in predicting disease outcome in hospitalized patients with COVID-19. PloS one, 2021, 16(8), e0256744. https://doi.org/10.1371/journal.pone.0256744
16. Riley R., Gilbert A. Widely Used Types and Clinical Applications of D-Dimer Assay. Lab Med. 2016, 47(2), 90-102. https://doi.org/10.1093/labmed/lmw001
17. Johnson E., Schell J., Rodgers G. The D-dimer assay. Am J Hematol. 2019, 94(7), 833-839. https://doi.org/10.1002/ajh.25482
18. Innocenti F., Lazzari C., Ricci F., Paolucci E., Agishev I., Pini R. D-Dimer Tests in the Emergency Department: Current Insights. Open access emergency medicine 2021, 13, 465–479. https://doi.org/10.2147/OAEM.S238696
19. Sikora-Skrabaka M., Skrabaka D., Ruggeri P., Caramori G., Skoczyński S., Barczyk A. D-dimer value in the diagnosis of pulmonary embolism-may it exclude only?. Journal of thoracic disease 2019, 11(3), 664–672. https://doi.org/10.21037/jtd.2019.02.88
20. Matsuo T., Kobayashi H., Kario K., Suzuki S. Fibrin D-dimer in thrombogenic disorders. Semin Thromb Hemost. 2000, 26(1), 101-107. https://doi.org/10.1055/s-2000-9811
21. Platonova T., Chernishenko T., Sokolovska L. Characteristics of D-domain-containing specific inhibitors of polymerization on the fibrin self-assembly process. Ukr Biokhim Zh. 2006, 78(3), 124-129.
22. Volkov G., Platonova T., Savchuk A., Gornytskaya O., Chernyshenko T., Krasnobryzhaya E. Modern ideas about the system of hemostasis. Kyiv, Scientific opinion. 2005, 317.